Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China flag China · Delayed Price · Currency is CNY
10.32
-0.19 (-1.81%)
At close: Apr 17, 2026

SHE:301301 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
4,2275,3974,5153,5743,055
Other Revenue
389.55361.61308.58246.72177.08
4,6165,7584,8233,8213,232
Revenue Growth (YoY)
-19.83%19.38%26.24%18.21%-11.44%
Cost of Revenue
3,2903,6803,3432,8902,637
Gross Profit
1,3262,0781,480930.89595.07
Selling, General & Admin
181.2190.87165.7155.54130.22
Research & Development
102.4977.7355.2635.3832.95
Other Operating Expenses
67.2179.5166.5254.9436.7
Operating Expenses
354.59341.43293.98260.12198.27
Operating Income
971.681,7371,186670.77396.8
Interest Expense
-33.82-61.91-87.78-142.34-176.88
Interest & Investment Income
4.667.3816.185.219.2
Currency Exchange Gain (Loss)
-0.386.6912.1814.71-5.37
Other Non Operating Income (Expenses)
-5.39-5.83-3.74-0.64-0.95
EBT Excluding Unusual Items
936.741,6831,123547.7222.8
Gain (Loss) on Sale of Investments
-5.74-9.16-14.73-8.960.55
Gain (Loss) on Sale of Assets
0.35-1.34-0.26
Asset Writedown
-1.39-1.25-1.28-0.68-5.79
Other Unusual Items
8.732.469.25-50.43-83.74
Pretax Income
938.691,6751,118487.63134.08
Income Tax Expense
170.34274.74177.1576.1122.73
Earnings From Continuing Operations
768.351,400940.56411.52111.35
Minority Interest in Earnings
0.66-0.03-00-0
Net Income
769.011,400940.56411.52111.35
Net Income to Common
769.011,400940.56411.52111.35
Net Income Growth
-45.08%48.88%128.56%269.58%-51.38%
Shares Outstanding (Basic)
2,2622,2232,2391,9601,856
Shares Outstanding (Diluted)
2,2622,2232,2391,9601,856
Shares Change (YoY)
1.76%-0.75%14.28%5.59%-7.21%
EPS (Basic)
0.340.630.420.210.06
EPS (Diluted)
0.340.630.420.210.06
EPS Growth
-46.03%50.00%100.00%250.00%-45.45%
Free Cash Flow
451.851,748947.26644.44750.94
Free Cash Flow Per Share
0.200.790.420.330.41
Dividend Per Share
0.1730.2700.2250.093-
Dividend Growth
-35.93%20.00%141.94%--
Gross Margin
28.73%36.09%30.69%24.37%18.41%
Operating Margin
21.05%30.16%24.59%17.56%12.28%
Profit Margin
16.66%24.32%19.50%10.77%3.45%
Free Cash Flow Margin
9.79%30.36%19.64%16.87%23.23%
EBITDA
1,5422,2781,7301,217919.79
EBITDA Margin
33.39%39.57%35.87%31.85%28.46%
D&A For EBITDA
569.86541.74543.6546.07522.99
EBIT
971.681,7371,186670.77396.8
EBIT Margin
21.05%30.16%24.59%17.56%12.28%
Effective Tax Rate
18.15%16.40%15.85%15.61%16.96%
Revenue as Reported
4,6165,7584,8233,8213,232
Source: S&P Global Market Intelligence. Standard template. Financial Sources.